232 related articles for article (PubMed ID: 9933442)
1. Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells.
Vallin H; Blomberg S; Alm GV; Cederblad B; Rönnblom L
Clin Exp Immunol; 1999 Jan; 115(1):196-202. PubMed ID: 9933442
[TBL] [Abstract][Full Text] [Related]
2. Anti-double-stranded DNA antibodies and immunostimulatory plasmid DNA in combination mimic the endogenous IFN-alpha inducer in systemic lupus erythematosus.
Vallin H; Perers A; Alm GV; Rönnblom L
J Immunol; 1999 Dec; 163(11):6306-13. PubMed ID: 10570325
[TBL] [Abstract][Full Text] [Related]
3. Patients with systemic lupus erythematosus have reduced numbers of circulating natural interferon-alpha- producing cells.
Cederblad B; Blomberg S; Vallin H; Perers A; Alm GV; Rönnblom L
J Autoimmun; 1998 Oct; 11(5):465-70. PubMed ID: 9802930
[TBL] [Abstract][Full Text] [Related]
4. The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer.
Båve U; Alm GV; Rönnblom L
J Immunol; 2000 Sep; 165(6):3519-26. PubMed ID: 10975873
[TBL] [Abstract][Full Text] [Related]
5. Expression of the markers BDCA-2 and BDCA-4 and production of interferon-alpha by plasmacytoid dendritic cells in systemic lupus erythematosus.
Blomberg S; Eloranta ML; Magnusson M; Alm GV; Rönnblom L
Arthritis Rheum; 2003 Sep; 48(9):2524-32. PubMed ID: 13130472
[TBL] [Abstract][Full Text] [Related]
6. Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.
Bengtsson AA; Sturfelt G; Truedsson L; Blomberg J; Alm G; Vallin H; Rönnblom L
Lupus; 2000; 9(9):664-71. PubMed ID: 11199920
[TBL] [Abstract][Full Text] [Related]
7. Activated T cells enhance interferon-α production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes.
Leonard D; Eloranta ML; Hagberg N; Berggren O; Tandre K; Alm G; Rönnblom L
Ann Rheum Dis; 2016 Sep; 75(9):1728-34. PubMed ID: 26493814
[TBL] [Abstract][Full Text] [Related]
8. Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG.
Båve U; Magnusson M; Eloranta ML; Perers A; Alm GV; Rönnblom L
J Immunol; 2003 Sep; 171(6):3296-302. PubMed ID: 12960360
[TBL] [Abstract][Full Text] [Related]
9. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
Wirestam L; Enocsson H; Skogh T; Eloranta ML; Rönnblom L; Sjöwall C; Wetterö J
Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
[TBL] [Abstract][Full Text] [Related]
10. The natural interferon-alpha producing cells in systemic lupus erythematosus.
Rönnblom L; Alm GV
Hum Immunol; 2002 Dec; 63(12):1181-93. PubMed ID: 12480262
[TBL] [Abstract][Full Text] [Related]
11. Activation of natural interferon-alpha producing cells by apoptotic U937 cells combined with lupus IgG and its regulation by cytokines.
Båve U; Vallin H; Alm GV; Rönnblom L
J Autoimmun; 2001 Aug; 17(1):71-80. PubMed ID: 11488639
[TBL] [Abstract][Full Text] [Related]
12. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG.
Lövgren T; Eloranta ML; Båve U; Alm GV; Rönnblom L
Arthritis Rheum; 2004 Jun; 50(6):1861-72. PubMed ID: 15188363
[TBL] [Abstract][Full Text] [Related]
13. Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus.
Blomberg S; Eloranta ML; Cederblad B; Nordlin K; Alm GV; Rönnblom L
Lupus; 2001; 10(7):484-90. PubMed ID: 11480846
[TBL] [Abstract][Full Text] [Related]
14. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.
Batteux F; Palmer P; Daëron M; Weill B; Lebon P
Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B infection and changes in interferon-alpha and -gamma production in patients with systemic lupus erythematosus in Taiwan.
Lu CL; Tsai ST; Chan CY; Hwang SJ; Tsai CY; Wu JC; Lu RH; Lin BC; Lee SD
J Gastroenterol Hepatol; 1997 Apr; 12(4):272-6. PubMed ID: 9195365
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the interferon-alpha production induced by RNA-containing immune complexes in plasmacytoid dendritic cells.
Eloranta ML; Lövgren T; Finke D; Mathsson L; Rönnelid J; Kastner B; Alm GV; Rönnblom L
Arthritis Rheum; 2009 Aug; 60(8):2418-27. PubMed ID: 19644885
[TBL] [Abstract][Full Text] [Related]
17. Anti-interferon alpha treatment in SLE.
Kirou KA; Gkrouzman E
Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
[TBL] [Abstract][Full Text] [Related]
18. Importance of CpG dinucleotides in activation of natural IFN-alpha-producing cells by a lupus-related oligodeoxynucleotide.
Magnusson M; Magnusson S; Vallin H; Rönnblom L; Alm GV
Scand J Immunol; 2001 Dec; 54(6):543-50. PubMed ID: 11902329
[TBL] [Abstract][Full Text] [Related]
19. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus.
Feng X; Chen W; Xiao L; Gu F; Huang J; Tsao BP; Sun L
Lupus; 2017 Jan; 26(1):62-72. PubMed ID: 27230555
[TBL] [Abstract][Full Text] [Related]
20. Enhanced IFN-α production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus.
Murayama G; Furusawa N; Chiba A; Yamaji K; Tamura N; Miyake S
Arthritis Res Ther; 2017 Oct; 19(1):234. PubMed ID: 29052537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
